Dermata疗法在私人股票销售中筹集2.55M美元,为研究和开发提供资金。 Dermata Therapeutics raises $2.55M in private stock sale to fund research and development.

专注于皮肤疾病的生物技术公司Dermata Therapeutics已完成255万美元的私募投资, Dermata Therapeutics, a biotech firm focused on skin diseases, has closed a $2.55 million private placement, issuing 2,007,880 shares of common stock and warrants at $1.27 per share. 这些资金将支助研究、临床试验、技术发展和潜在的收购。 The funds will support research, clinical trials, technology development, and potential acquisitions. 公司内部人员,包括执行官,参加了这项提议。 Company insiders, including executives, participated in the offering. H.C. Wainwright & Co.担任安置代理人。 H.C. Wainwright & Co. acted as the placement agent.